ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI
20-12-15	Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	CI
20-07-20	ACell, Inc. has withdrawn its IPO in the amount of $80 million.	CI
20-06-26	ACell, Inc. has filed an IPO in the amount of $86.25 million.	CI
19-09-05	ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	CI
19-09-04	ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	CI
19-04-08	ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	CI
18-10-15	ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	CI
18-10-08	ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	CI
18-07-20	ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	CI
18-05-08	ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	CI
18-04-11	ACell, Inc. Announces Launch of Gentrix® Incisional	CI

Manager	Title	Age	Since
Matthew R. Kunst DFI	Director of Finance/CFO	-	2019-12-31
Patty Meehan ADM	Chief Administrative Officer	-	2001-12-31
Jim Kuras CTO	Chief Tech/Sci/R&D Officer	-	2019-12-31

Director	Title	Age	Since
John J. McDonnell BRD	Director/Board Member	59	-
Martin Pfinsgraff BRD	Director/Board Member	71	2019-06-30
Kyle C. Kerbawy CHM	Chairman	79	2015-07-31

ACell, Inc. Stock

Stocks

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Latest news : ACell, Inc.

News in other languages: ACell, Inc.

Managers and Directors: ACell, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACELL, INC.	-.--%	-.--%	-	-	340M
ABBOTT LABORATORIES	+2.95%	+1.83%	-29.20%	-11.44%	161B
MEDTRONIC PLC	+4.17%	+2.43%	-6.58%	-5.35%	101B
CENCORA, INC.	+1.95%	+2.33%	+0.84%	+53.79%	56.12B
HOYA CORPORATION	-1.22%	-2.88%	+53.69%	+49.87%	53.35B
BECTON, DICKINSON AND COMPANY	+2.48%	+3.47%	-11.64%	-40.20%	42.13B
MEDLINE INC.	+2.58%	+13.53%	-	-	35.29B
DEXCOM, INC.	+3.42%	+3.86%	-14.69%	-43.87%	26.57B
WEST PHARMACEUTICAL SERVICES, INC.	+0.02%	+5.44%	+65.18%	-3.41%	25.79B
STERIS PLC	+2.03%	+2.83%	-9.11%	-1.18%	20.69B
Average	+1.85%	+2.80%	+6.06%	-0.22%	52.22B
Weighted average by Cap.	+2.44%	+2.00%	-3.76%	+0.67%

	2018	2019
Net sales	89.22M 77.96M 71.59M 66.76M 127M 8.49B 129M 862M 334M 4.17B 335M 328M 14.36B	101M 88.07M 80.88M 75.42M 143M 9.6B 145M 974M 377M 4.71B 378M 370M 16.22B
Net income	-3.13M -2.74M -2.51M -2.34M -4.44M -298M -4.52M -30.25M -11.72M -146M -11.76M -11.5M -504M	1.45M 1.27M 1.16M 1.08M 2.06M 138M 2.09M 14M 5.42M 67.65M 5.44M 5.32M 233M
Net Debt	-	-